Transcriptomics Market Report 2026

Transcriptomics Market Overview

• Transcriptomics market size has reached to $7.04 billion in 2025 • Expected to grow to $10.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Adoption Of Personalized Medicine Drives The Market Growth Due to Improved Treatment Precision And Patient Outcomes • Market Trend: Advancements In Single-Cell Spatial Transcriptomics Enhance Cellular And Tissue-Level Insights • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transcriptomics Market?

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts produced by the genome in a specific cell, tissue, or condition. It helps decode gene expression patterns and regulatory mechanisms, revealing how these change in response to diseases or environmental factors. This field offers deep insights into cellular functions and disease pathways. Transcriptomics is crucial for biomarker discovery, therapeutic target identification, and advancing personalized medicine. The main types of transcriptomics are instruments, consumables, software, and services. Instruments are essential tools in transcriptomics, enabling precise analysis of gene expression through high-throughput sequencing, amplification, and RNA detection. It utilizes various technologies such as microarray, real-time quantitative polymerase chain reaction, and sequencing technologies for several applications, including diagnostics and disease profiling, drug discovery, and others, and is used by various end-users such as academic and research institutes, pharmaceutical companies, biotechnology companies, and others.

What Is The Transcriptomics Market Growth Forecast?

The transcriptomics market size is expected to see strong growth in the next few years. It will grow to $10.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing integration of ai-driven data analysis, rising demand for personalized therapeutics, expansion of clinical transcriptomics applications, growing investments in omics research infrastructure, increasing pharmaceutical adoption of transcriptomic profiling. Major trends in the forecast period include increasing adoption of rna sequencing technologies, growing use of single-cell transcriptomics, expansion of bioinformatics and data analytics platforms, rising demand for biomarker discovery applications, enhanced focus on precision medicine.

Global Transcriptomics Market Segmentation

1) By Type: Instruments, Consumables, Software, Services 2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies 3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications 4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users Subsegments: 1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments 2) By Consumables: Reagents, Probes, Kits, Chips 3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software 4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services

What Is The Driver Of The Transcriptomics Market?

The increasing adoption of personalized medicine is expected to propel the growth of the transcriptomics market going forward. Personalized medicine refers to a medical approach that customizes treatment based on an individual’s genetic profile, lifestyle, and environment. Personalized medicine is growing due to advances in genetic sequencing, enabling treatments tailored to individual genetic profiles for better effectiveness. Transcriptomics uncovers individual gene expression profiles, guiding personalized treatments based on a patient’s unique biology. It enhances therapeutic effectiveness, minimizes side effects, and enables early disease diagnosis. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the transcriptomics industry.

Key Players In The Global Transcriptomics Market

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Global Transcriptomics Market Trends and Insights

Major companies operating in the transcriptomics market are focused on developing advanced products such as single-cell spatial panels to drive deeper insights into cellular functions and disease mechanisms. Single-cell spatial panels analyze gene expression at the individual cell level while maintaining each cell’s position within the tissue. They merge single-cell transcriptomics with spatial data, offering insights into both cellular activity and tissue architecture. For instance, in February 2024, NanoString Technologies, a US-based biotechnology company, launched the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay. This launch marks the commercial availability of the industry’s first single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This breakthrough, designed for use with the CosMx Spatial Molecular Imager (SMI), enables researchers to profile genes at single-cell and subcellular resolution with high accuracy and advanced cell segmentation.

What Are Latest Mergers And Acquisitions In The Transcriptomics Market?

In July 2024, Illumina, Inc., a US-based provider of DNA sequencing and array-based technologies, acquired Fluent BioSciences Inc. for an undisclosed amount. The acquisition aims to expand Illumina’s multiomics capabilities by integrating Fluent’s innovative, scalable single-cell technology, which eliminates the need for complex and costly instrumentation, thus lowering barriers for researchers and enabling more rapid, economical, and comprehensive discovery in genomics and cell biology. Fluent BioSciences Inc. is a US-based provider of single-cell analysis technology, a core method in transcriptomics that allows researchers to profile gene expression at the individual cell level.

Regional Outlook

North America was the largest region in the transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Transcriptomics Market?

The transcriptomics market consists of revenues earned by entities by providing services such as voice gene expression analysis, ribonucleic acid sequencing, bioinformatics solutions, and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The transcriptomics market also includes sales of RNA extraction kits, library preparation kits, and cDNA synthesis kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transcriptomics Market Report 2026?

The transcriptomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transcriptomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.